• Viking Therapeutics to Present at Stifel 2022 Healthcare Conference

    19 days ago - By San Diego Biotechnology

    SAN DIEGO, Nov. 8, 2022 /PRNewswire/ - Viking Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced that its chief executive...
    Read more ...

     

  • Avidity Biosciences Reports Third Quarter 2022 Financial Results and Recent Highlights

    19 days ago - By San Diego Biotechnology

    Company has three distinct rare disease programs in clinical development - myotonic dystrophy type 1 , facioscapulohumeral muscular dystrophy , and Duchenne muscular dystrophy On track for preliminary assessment of AOC 1001 MARINA™ trial...
    Read more ...

     

  • Heron Therapeutics Announces Financial Results for the Three and Nine Months Ended September 30, 2022 and Highlights Recent Corporate Updates

    19 days ago - By San Diego Biotechnology

    APONVIE™ approval by FDA, U.S. launch planned for Q1 2023 - ZYNRELEF® unit demand grew 18% over prior quarter in Q3 2022 - Oncology Care Franchise net product sales grew 13% over...
    Read more ...

     

  • CV SCIENCES, INC. TO ANNOUNCE THIRD QUARTER 2022 RESULTS ON NOVEMBER 14, 2022

    19 days ago - By San Diego Biotechnology

    SAN DIEGO, Nov. 8, 2022 /PRNewswire/ - CV Sciences, Inc. (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and manufacturer of hemp cannabidiol products, today announced that it will release...
    Read more ...

     

  • Mirati Therapeutics Reports Third Quarter 2022 Financial Results and Recent Corporate Updates

    19 days ago - By San Diego Biotechnology

    SAN DIEGO, Nov. 8, 2022 /PRNewswire/ - Mirati Therapeutics, Inc. , a clinical-stage targeted oncology company, today reported financial results for the third quarter of 2022 and recent corporate updates. “In the third quarter,...
    Read more ...